FERRANTE, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 5.284
EU - Europa 4.672
AS - Asia 3.959
SA - Sud America 363
AF - Africa 154
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.458
Nazione #
US - Stati Uniti d'America 5.058
CN - Cina 1.326
GB - Regno Unito 1.299
SG - Singapore 1.100
IT - Italia 868
DE - Germania 765
SE - Svezia 458
HK - Hong Kong 341
RU - Federazione Russa 294
BD - Bangladesh 290
VN - Vietnam 289
BR - Brasile 238
FR - Francia 219
IN - India 203
CA - Canada 179
UA - Ucraina 152
NL - Olanda 147
FI - Finlandia 131
TR - Turchia 105
KR - Corea 92
IE - Irlanda 88
CI - Costa d'Avorio 87
EU - Europa 47
JP - Giappone 45
ES - Italia 43
BE - Belgio 42
ID - Indonesia 42
CO - Colombia 41
DK - Danimarca 38
AR - Argentina 30
AU - Australia 19
ZA - Sudafrica 19
PL - Polonia 18
MX - Messico 16
DZ - Algeria 15
RO - Romania 15
SA - Arabia Saudita 15
CL - Cile 14
PK - Pakistan 14
TW - Taiwan 14
CH - Svizzera 13
EC - Ecuador 13
UZ - Uzbekistan 13
AT - Austria 12
CZ - Repubblica Ceca 11
PT - Portogallo 11
GR - Grecia 9
PH - Filippine 8
MA - Marocco 7
BO - Bolivia 6
IQ - Iraq 6
PY - Paraguay 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
VE - Venezuela 6
BA - Bosnia-Erzegovina 5
HN - Honduras 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PE - Perù 5
SI - Slovenia 5
TH - Thailandia 5
CR - Costa Rica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PR - Porto Rico 4
QA - Qatar 4
SN - Senegal 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
IR - Iran 3
MY - Malesia 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
GY - Guiana 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
Totale 14.491
Città #
Southend 1.129
Dallas 844
Singapore 646
Ashburn 512
Chandler 388
Hong Kong 291
Hanover 262
Houston 259
San Jose 255
Milan 247
Beijing 244
Ann Arbor 202
Seattle 142
New York 135
Santa Clara 124
Los Angeles 123
Council Bluffs 121
Toronto 114
Princeton 110
Jacksonville 105
Wilmington 90
Dearborn 89
Dublin 87
Abidjan 86
Ho Chi Minh City 84
Frankfurt am Main 83
Bengaluru 80
Hefei 78
Buffalo 73
Boardman 67
Helsinki 67
Hanoi 65
Woodbridge 64
Fairfield 62
Lauterbourg 57
Mountain View 57
Nanjing 57
Serra 56
Redmond 52
Guangzhou 48
Moscow 47
Des Moines 46
Fuzhou 44
Rome 44
Shenyang 41
Columbus 37
Shanghai 36
Brussels 34
Munich 34
Somerville 34
Redwood City 32
Bogotá 31
The Dalles 30
Tianjin 30
Sakarya 29
Phoenix 28
Jinan 27
Tokyo 27
Andover 26
Hangzhou 26
Seoul 24
Changsha 23
Zhengzhou 23
Cangzhou 21
Naples 21
Jakarta 20
Bitonto 19
Nanchang 19
Kiez 18
San Diego 18
Chicago 17
London 17
São Paulo 17
Berlin 16
Cambridge 16
Turin 16
Amsterdam 15
Mumbai 15
Ottawa 15
Turku 15
Da Nang 14
Edinburgh 14
Hebei 14
Johannesburg 14
Istanbul 13
Montreal 13
Shenzhen 13
Auburn Hills 12
Dong Ket 12
Nürnberg 12
Verona 12
Warsaw 12
Atlanta 11
Düsseldorf 11
Pisa 11
Pune 11
Barcelona 10
Bologna 10
Chengdu 10
Jiaxing 10
Totale 8.942
Nome #
Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia : first Italian series 660
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma 431
Biallelic expression of the Gsalpha gene in human bone and adipose tissue 429
Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study 422
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 422
A Case Report of Severe Hypotonic Hyponatremia Secondary to Concomitant Intake of Desmopressin Replacement Therapy and Non-Steroidal Anti-Inflammatory Drugs 330
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 321
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency 314
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein 311
Efficacy and tolerability of gamma knife radiosurgery in acromegaly : a 10-year follow-up study 307
SARS-CoV-2-related atypical thyroiditis 278
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly : effects on cardiovascular risk factors 276
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 275
Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency 274
Efficacia e tollerabilità della radiochirurgia con tecnica gamma-knife nell’acromegalia : studio con follow-up pari a 10 anni 267
Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency 261
Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin : a case report and review of the literature 257
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 254
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 254
Prevalence of GH deficiency in cured acromegalic patients : impact of different previous treatments 252
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 242
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency 240
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 237
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 234
Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 233
Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas : focus on the Prevalence of Isolated Central Hypoadrenalism 231
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 224
Progressive bone impairment with age and pubertal development in neurofibromatosis type I 223
Detection of small bowel tumors by videocapsule endoscopy in patients with acromegaly 221
Efficacy and tolerability of gamma knife radiosurgery in acromegaly : a 10-year follow-up study 219
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly 217
Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults 216
GH response to oral glucose tolerance test : a comparison between patients with acromegaly and other pituitary disorders 214
Growth hormone replacement therapy in growth hormone deficient children and adults : effects on hemochrome 213
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 212
Diagnostic features and outcome of surgical therapy of acromegalic patients : experience of the last three decades 209
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas 207
Evaluation of GH-IGF-I axis in adult patients with coeliac disease 200
Central hypothyroidism and growth hormone treatment : clinical care 197
Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype 193
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells 192
Evaluation of the Components of the Insulin-like Growth Factors System in GH-deficient Adults: Effects of Twelve-month rhGH Treatment 190
Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients 189
Arterial Embolization and Second-Look in Spindle Cell Oncocytoma of the Pituitary Gland : Case Report and Review of Literature 188
Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series 186
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes 184
Expression of the antiaptotic gene seladin-1 and octreotide-induced aptosis in growth hormone-secreting and non functioning pituitary adenomas 181
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 179
Prevalence and determinants of radiological vertebral fractures in patients with Klinefelter syndrome 177
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 177
Non-functioning pituitary adenoma database : a useful resource to improve the clinical management of pituitary tumors 176
Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy 175
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas 174
Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas 173
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 165
Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance 155
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors 147
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 137
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 137
La diagnostica del diabete insipido 131
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas 126
The suprasellar volume of nonfunctioning pituitary adenomas: a useful tool for predicting visual field deficits 114
COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy 81
Macro-FSH is a rare cause of inappropriately high FSH concentrations 63
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study 62
Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer 62
Exploring the Role of Skull Base Anatomy in Surgical Approach Selection and Endocrinological Outcomes in Craniopharyngiomas 58
Neuropsychological profile in acromegaly: a single center cross sectional analysis and preliminary prospective long-term study 29
Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology 25
Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria? 3
null 3
Totale 15.016
Categoria #
all - tutte 35.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/20221.023 51 19 86 39 94 65 93 65 173 101 74 163
2022/20231.105 132 158 113 140 106 198 21 58 104 12 34 29
2023/2024726 32 63 48 56 228 35 41 51 17 29 59 67
2024/20251.886 71 154 30 178 149 82 74 191 110 203 211 433
2025/20265.362 451 929 518 366 370 276 616 163 460 373 685 155
Totale 15.016